Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02319577
What this trial is testing

GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 80
Testing effectiveness (Phase 2)UnknownNCT02484755
What this trial is testing

Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease

Who this might be right for
Cushing's DiseaseCorticotrophin Adenoma
Huashan Hospital 6
Testing effectiveness (Phase 2)Study completedNCT01513174
What this trial is testing

Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 186
Testing effectiveness (Phase 2)Study completedNCT00025350
What this trial is testing

Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT02039674
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)

Who this might be right for
Non-small Cell Lung Carcinoma
Merck Sharp & Dohme LLC 267
Not applicableUnknownNCT03647592
What this trial is testing

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 30
Large-scale testing (Phase 3)UnknownNCT01579630
What this trial is testing

Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy

Who this might be right for
NSCLC
Taipei Veterans General Hospital, Taiwan 52
Large-scale testing (Phase 3)WithdrawnNCT00090675
What this trial is testing

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07829926
What this trial is testing

Lenvatinib Plus Tislelizumab With or Without Gefitinib for Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)
First Affiliated Hospital of Wenzhou Medical University 120
Not applicableUnknownNCT01697163
What this trial is testing

De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Who this might be right for
NSCLC
Severance Hospital 155
Testing effectiveness (Phase 2)Study completedNCT00049062
What this trial is testing

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio
Testing effectiveness (Phase 2)Study completedNCT00268346
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT02856893
What this trial is testing

Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)

Who this might be right for
NSCLC
European Organisation for Research and Treatment of Cancer - EORTC 156
Early research (Phase 1)Study completedNCT01090011
What this trial is testing

Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 171
Testing effectiveness (Phase 2)Study completedNCT00015964
What this trial is testing

ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
University of Chicago 51
Testing effectiveness (Phase 2)Study completedNCT01469000
What this trial is testing

Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non Small Cell Lung
Eli Lilly and Company 195
Testing effectiveness (Phase 2)Study completedNCT00319787
What this trial is testing

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

Who this might be right for
Locally Advanced Prostate Cancer
AstraZeneca 102
Large-scale testing (Phase 3)Study completedNCT00478049
What this trial is testing

Iressa as Second Line Therapy in Advanced NSCLC-Asia

Who this might be right for
NSCLC
AstraZeneca 163
Not applicableStudy completedNCT01103089
What this trial is testing

Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 10
Testing effectiveness (Phase 2)UnknownNCT00423397
What this trial is testing

Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
University of California, San Diego 16
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation